Search for: "NOVARTIS AG" Results 21 - 40 of 440
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jul 2014, 9:31 pm by Patent Docs
Reg. 34681) discussing changes to the rules of practice to implement the Federal Circuit's decision in Novartis AG v. [read post]
16 Mar 2015, 9:59 pm by Patent Docs
Reg. 1346) to revise the rules of practice to implement the Federal Circuit's decision in Novartis AG v. [read post]
6 Dec 2006, 6:01 am
said a U.S. federal court (D NJ) granted a temporary restraining order [TRO] enjoining all sales of generic oxandrolone tablets by Novartis AG'S Sandoz Pharmaceuticals, and Upsher-Smith Laboratories. [read post]
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending September… [read post]
7 Jan 2021, 1:32 pm by Tom Lamb
To start, Beovu was approved by the FDA on October 7, 2019, to treat wet age-related macular degeneration. [read post]
3 Nov 2015, 12:13 pm by Fraud Fighters
Novartis AG, a European based pharmaceutical company, agreed to settle a False Claims Act (FCA) lawsuit for $390 million, a week before the original $3.3 billion FCA lawsuit was set to go to trial on November 2, 2015. [read post]
The court said that the generic companies’ manufacturing or selling of these tablets may amount to infringement of a patent owned by major pharmaceutical company Novartis AG. [read post]
1 Feb 2012, 1:50 pm by info@thomasjhenrylaw.com
Food and Drug Administration (FDA) to change the label for Focalin, an attention deficit medicine made by Swiss drug-maker Novartis AG, to reflect the increased risk of suicidal thoughts in children taking the medication. [read post]
11 Oct 2012, 5:16 pm by Maine Employee Rights Group
First Circuit Court of Appeals reversed a trial court's decision to dismiss an age discrimination case against Novartis Ex-Lax, Inc. [read post]
10 Jul 2010, 1:53 pm
According to a recent wage and hour ruling that our Riverside, California employment attorneys have been following, sales representatives of Novartis AG, are supported by federal, New York state, and California state wage and hour laws that require overtime compensation. [read post]
29 Jun 2018, 11:13 am
In its ruling,  the Court ordered Teva to pay Novartis more than €13,000,000 as an advance on damages (€5,846,628 to Novartis Pharma AG, the Swiss company which owns the patent, and €7,308,285 to Novartis Pharma SAS, the French licensee). [read post]
23 Dec 2022, 1:31 am
Author Dfrg.msc Public Domain Source Wikimedia Commons Jane LambertCourt of Appeal (Lords Justices Arnold and Nugee and Sir Christopher Floyd) Teva UK Ltd and another v Novartis AG  [2022] EWCA Civ 1617 (8 Dec 2022)This was an appeal against Mrs Justice Bacon's refusal to grant an Arrow declaration in Teva UK Ltd and another v Novartis AG [2022] EWHC 2779 (Ch) (19 Oct 2022). [read post]
13 Aug 2020, 7:34 am by Geoff Schweller
  One of the newly posted Notices refers to a case where the SEC and Novartis AG (Novartis) settled charges that Novartis violated the Foreign and Corrupt Practices Act (FCPA). [read post]
19 Nov 2012, 11:00 pm by Courtenay Brinckerhoff
In another significant Patent Term Adjustment (PTA) case decided last week (Novartis AG v. [read post]
23 Jan 2015, 4:58 am by Geoff Cockrell
The company — dRx Capital AG — will invest up to $100 million to support early stage digital health companies. [read post]
4 Mar 2020, 1:56 pm by Tom Lamb
Most of the cases have started after patients’ first or second injection of the wet age-related macular degeneration (AMD) drug, Novartis said. [read post]
23 Feb 2010, 11:48 am by admin
., a subsidiary of Swiss company Novartis AG, submitted false reports to the government between April 1999 and September 2008 that misrepresented Nitroglycerin SR’s regulatory status and failed to advise that the drug did not qualify for Medicaid coverage. [read post]
30 Oct 2020, 1:30 pm by Tom Lamb
Beovu Legal Cases Involve Retinal Artery Occlusion, Retinal Vasculitis, Intraocular Inflammation, Other Eye Problems   (Posted by Tom Lamb at DrugInjuryWatch.com)   Beovu (brolucizumab) is prescribed for the treatment of neovascular (wet) age-related macular degeneration (AMD). [read post]